Latest news
LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeatMarketBeat · Thu, 06 Aug 2026 09:03:47 GMTHC Wainwright Issues Optimistic Estimate for LBRX Earnings - MarketBeatMarketBeat · Wed, 05 Aug 2026 11:09:38 GMTAnalysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), LB Pharmaceuticals, Inc. (LBRX) and SpaceX (SPCX) - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 11:30:00 GMTPrice to sales forward of LB Pharmaceuticals Inc – NASDAQ:LBRX - TradingViewTradingView · Tue, 04 Aug 2026 07:08:07 GMTLB Pharmaceuticals (LBRX) holder acquires 286K pre-funded warrants - Stock TitanStock Titan · Mon, 03 Aug 2026 23:28:59 GMTStempoint Capital LP Takes $1.23 Million Position in LB Pharmaceuticals Inc $LBRX - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTLB Pharmaceuticals raises USD 150m to expand LB-102 into three neuropsychiatric indications - AllSciAllSci · Wed, 29 Jul 2026 16:15:58 GMTLB Pharmaceuticals Prices ~$150 Million Private Placement of Stock and Pre-Funded Warrants - TradingViewTradingView · Wed, 29 Jul 2026 12:13:01 GMT